A new era for patient recruitment and retention in rare disease

Published on February 28, 2024

Pharma and biotech organizations continue to prioritize the diversification of their pipelines to innovate more in areas of high and rare unmet need. In addition to delivering life-saving treatments to patients who have had historically limited therapeutic options, addressing high and rare unmet needs can lead to faster routes to market with accelerated regulatory pathways […]

Continue reading on website
Other news

Scientific Poster: Custom Designed Linker-Payload Synthesis & Bioconjugation towards ADC Development

February 28, 2024
AbstractAbzena has decades of experience in the custom synthesis of complex novel linker-payloads. With a focus on providing the best synthetic routes, we have designed and synthesized thousands of payloads and linker-payloads.We synthesize custom designed linker-payloads utilizing our toolbox approach to maximize the number of compounds that can be generated in the shortest timeline possible. Our

InnovAge Launches First PACE Center in Florida Providing Comprehensive Healthcare Program for Seniors to Promote Independence

March 4, 2024
TAMPA, Fla., March 04, 2024 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. (“InnovAge”) (Nasdaq: INNV), the industry leader in providing comprehensive healthcare programs to dual-eligible seniors through the Program of All-inclusive Care for the Elderly (PACE) launched a new center in Tampa, its first